Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Non-invasive Cancer Diagnosis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Non-invasive Cancer Diagnosismarket, defines the market attractiveness level of Non-invasive Cancer Diagnosis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Non-invasive Cancer Diagnosis industry, describes the types of Non-invasive Cancer Diagnosis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-invasive Cancer Diagnosis market and the development prospects and opportunities of Non-invasive Cancer Diagnosis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-invasive Cancer Diagnosis market in Chapter 13.
By Player:
LabCorp
BioView Inc
Gen-Probe Inc
Digene Corporation
Affymetrix Inc
A&G Pharmaceutical
AVIVA Biosciences Corporation
Precision Therapeutics
Quest Diagnostics Inc
By Type:
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others
By End-User:
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Non-invasive Cancer Diagnosis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Non-invasive Cancer Diagnosis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Non-invasive Cancer Diagnosis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Non-invasive Cancer Diagnosis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Non-invasive Cancer Diagnosis Market Analysis and Outlook to 2022
-
7.1 Global Non-invasive Cancer Diagnosis Consumption (2017-2022)
-
7.2 United States Non-invasive Cancer Diagnosis Consumption (2017-2022)
-
7.3 Europe Non-invasive Cancer Diagnosis Consumption (2017-2022)
-
7.4 China Non-invasive Cancer Diagnosis Consumption (2017-2022)
-
7.5 Japan Non-invasive Cancer Diagnosis Consumption (2017-2022)
-
7.6 India Non-invasive Cancer Diagnosis Consumption (2017-2022)
-
7.7 South Korea Non-invasive Cancer Diagnosis Consumption (2017-2022)
8 Region and Country-wise Non-invasive Cancer Diagnosis Market Analysis and Outlook to 2028
-
8.1 Global Non-invasive Cancer Diagnosis Consumption Forecast (2022-2028)
-
8.2 United States Non-invasive Cancer Diagnosis Consumption Forecast (2022-2028)
-
8.3 Europe Non-invasive Cancer Diagnosis Consumption Forecast (2022-2028)
-
8.4 China Non-invasive Cancer Diagnosis Consumption Forecast (2022-2028)
-
8.5 Japan Non-invasive Cancer Diagnosis Consumption Forecast (2022-2028)
-
8.6 India Non-invasive Cancer Diagnosis Consumption Forecast (2022-2028)
-
8.7 South Korea Non-invasive Cancer Diagnosis Consumption Forecast (2022-2028)
9 Global Non-invasive Cancer Diagnosis Market Outlook by Types and Applications to 2022
-
9.1 Global Non-invasive Cancer Diagnosis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Clinical Chemistry Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunochemistry/Immunoassay Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Non-invasive Cancer Diagnosis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Solid Tumors Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Non-invasive Cancer Diagnosis Market Outlook by Types and Applications to 2028
-
10.1 Global Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Clinical Chemistry Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunochemistry/Immunoassay Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Non-invasive Cancer Diagnosis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Non-invasive Cancer Diagnosis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Non-invasive Cancer Diagnosis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Non-invasive Cancer Diagnosis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Non-invasive Cancer Diagnosis Market Competitive Analysis
-
14.1 LabCorp
-
14.1.1 LabCorp Company Details
-
14.1.2 LabCorp Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 LabCorp Non-invasive Cancer Diagnosis Product and Service
-
14.2 BioView Inc
-
14.2.1 BioView Inc Company Details
-
14.2.2 BioView Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 BioView Inc Non-invasive Cancer Diagnosis Product and Service
-
14.3 Gen-Probe Inc
-
14.3.1 Gen-Probe Inc Company Details
-
14.3.2 Gen-Probe Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Gen-Probe Inc Non-invasive Cancer Diagnosis Product and Service
-
14.4 Digene Corporation
-
14.4.1 Digene Corporation Company Details
-
14.4.2 Digene Corporation Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Digene Corporation Non-invasive Cancer Diagnosis Product and Service
-
14.5 Affymetrix Inc
-
14.5.1 Affymetrix Inc Company Details
-
14.5.2 Affymetrix Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Affymetrix Inc Non-invasive Cancer Diagnosis Product and Service
-
14.6 A&G Pharmaceutical
-
14.6.1 A&G Pharmaceutical Company Details
-
14.6.2 A&G Pharmaceutical Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Product and Service
-
14.7 AVIVA Biosciences Corporation
-
14.7.1 AVIVA Biosciences Corporation Company Details
-
14.7.2 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product and Service
-
14.8 Precision Therapeutics
-
14.8.1 Precision Therapeutics Company Details
-
14.8.2 Precision Therapeutics Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Precision Therapeutics Non-invasive Cancer Diagnosis Product and Service
-
14.9 Quest Diagnostics Inc
-
14.9.1 Quest Diagnostics Inc Company Details
-
14.9.2 Quest Diagnostics Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Quest Diagnostics Inc Non-invasive Cancer Diagnosis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Non-invasive Cancer Diagnosis
-
Figure Non-invasive Cancer Diagnosis Picture
-
Table Global Non-invasive Cancer Diagnosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Non-invasive Cancer Diagnosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Non-invasive Cancer Diagnosis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Non-invasive Cancer Diagnosis Consumption by Country (2017-2022)
-
Figure United States Non-invasive Cancer Diagnosis Consumption and Growth Rate (2017-2022)
-
Table Europe Non-invasive Cancer Diagnosis Consumption and Growth Rate (2017-2022)
-
Figure China Non-invasive Cancer Diagnosis Consumption and Growth Rate (2017-2022)
-
Figure Japan Non-invasive Cancer Diagnosis Consumption and Growth Rate (2017-2022)
-
Figure India Non-invasive Cancer Diagnosis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Non-invasive Cancer Diagnosis Consumption and Growth Rate (2017-2022)
-
Figure Global Non-invasive Cancer Diagnosis Consumption Forecast by Country (2022-2028)
-
Figure United States Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Non-invasive Cancer Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical Chemistry Consumption and Growth Rate (2017-2022)
-
Figure Global Immunochemistry/Immunoassay Consumption and Growth Rate (2017-2022)
-
Figure Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumors Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical Chemistry Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunochemistry/Immunoassay Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Non-invasive Cancer Diagnosis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Non-invasive Cancer Diagnosis Export by Region (Top 5 Countries) (2017-2028)
-
Table LabCorp (Foundation Year, Company Profile and etc.)
-
Table LabCorp Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table LabCorp Non-invasive Cancer Diagnosis Product and Service
-
Table BioView Inc (Foundation Year, Company Profile and etc.)
-
Table BioView Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioView Inc Non-invasive Cancer Diagnosis Product and Service
-
Table Gen-Probe Inc (Foundation Year, Company Profile and etc.)
-
Table Gen-Probe Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gen-Probe Inc Non-invasive Cancer Diagnosis Product and Service
-
Table Digene Corporation (Foundation Year, Company Profile and etc.)
-
Table Digene Corporation Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Digene Corporation Non-invasive Cancer Diagnosis Product and Service
-
Table Affymetrix Inc (Foundation Year, Company Profile and etc.)
-
Table Affymetrix Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affymetrix Inc Non-invasive Cancer Diagnosis Product and Service
-
Table A&G Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table A&G Pharmaceutical Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table A&G Pharmaceutical Non-invasive Cancer Diagnosis Product and Service
-
Table AVIVA Biosciences Corporation (Foundation Year, Company Profile and etc.)
-
Table AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product and Service
-
Table Precision Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Precision Therapeutics Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Precision Therapeutics Non-invasive Cancer Diagnosis Product and Service
-
Table Quest Diagnostics Inc (Foundation Year, Company Profile and etc.)
-
Table Quest Diagnostics Inc Non-invasive Cancer Diagnosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Inc Non-invasive Cancer Diagnosis Product and Service
-
